By expenditures
| Name | Title | Type |
|---|---|---|
| Mary Vandal | BUSINESS MANAGER | Auditee |
| Matt Laughlin | Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 350113 | 2024 | 2025-03-28 | Brady Martz & Associates PC | $6.27M |
| 15218 | 2023 | 2024-02-02 | Brady Martz & Associates PC | $8.46M |
| 50718 | 2022 | 2023-03-05 | Brady Martz & Associates PC | $7.26M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 350113 | 2024 | 2025-03-28 | 1116005 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 1116004 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 1116003 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 1116002 | 2024-005 | Significant Deficiency | - | L |
| 350113 | 2024 | 2025-03-28 | 539563 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 539562 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 539561 | 2024-004 | Significant Deficiency | Yes | AB |
| 350113 | 2024 | 2025-03-28 | 539560 | 2024-005 | Significant Deficiency | - | L |
| 15218 | 2023 | 2024-02-02 | 587782 | 2023-004 | Significant Deficiency | - | AB |
| 15218 | 2023 | 2024-02-02 | 587781 | 2023-004 | Significant Deficiency | - | AB |
| 15218 | 2023 | 2024-02-02 | 587780 | 2023-004 | Significant Deficiency | - | AB |
| 15218 | 2023 | 2024-02-02 | 11340 | 2023-004 | Significant Deficiency | - | AB |
| 15218 | 2023 | 2024-02-02 | 11339 | 2023-004 | Significant Deficiency | - | AB |
| 15218 | 2023 | 2024-02-02 | 11338 | 2023-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 620176 | 2022-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 620175 | 2022-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 620174 | 2022-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 43734 | 2022-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 43733 | 2022-004 | Significant Deficiency | - | AB |
| 50718 | 2022 | 2023-03-05 | 43732 | 2022-004 | Significant Deficiency | - | AB |